| HGNC Family | Zinc fingers |
| Name | ZFP2 zinc finger protein |
| Description | Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMatrix metalloproteinase‐2 (MMP‑2) has emerged as a key effector in extracellular matrix remodeling and proteolysis, acting to cleave various matrix components and thereby modulating tissue architecture. In vascular disease models, MMP‑2 collaborates with MMP‑9 to permit cellular invasion that underlies processes such as aortic aneurysm formation, while its up‐regulation in response to mechanical stretch underscores its involvement in hypertensive vascular remodeling. Moreover, studies in inflammatory arthritis and elastin calcification further reveal that MMP‑2 is integral to the balance between matrix degradation and repair, contributing both to pathologic tissue destruction as well as to regulated remodeling."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "7"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn tumor biology and wound repair, MMP‑2 facilitates cancer cell adhesion, invasion and metastasis by cleaving extracellular matrix proteins and liberating bioactive fragments that modulate integrin signaling and growth factor availability. It is also implicated in branching morphogenesis during mammary gland development and in neuropathic pain models where its delayed up‐regulation contributes to late-phase cytokine activation. Complementary work using prodrug constructs and microRNA manipulation highlights a regulatory nexus in which MMP‑2 expression and activity are controlled at multiple levels, thereby influencing both cell motility and tissue homeostasis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "8", "end_ref": "22"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAt the interface of inflammation and immune cell trafficking, MMP‑2 regulates barrier permeability and supports cell migration through the degradation of basement membrane components. In experimental models of lymphocyte extravasation, as well as in studies of central nervous system inflammation and post‐infarct cardiac remodeling, MMP‑2’s proteolytic activity helps to modulate chemokine gradients and extracellular environments, thus facilitating immune cell egression and wound healing. This dynamic balance is evident in models of colitis, atherosclerosis and myocardial infarction, where altered MMP‑2 levels are associated with both protective and deleterious outcomes."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "23", "end_ref": "33"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nSignal transduction studies have illustrated that MMP‑2 activity is tightly regulated by upstream pathways including PI3‑kinase/Akt/mTOR and MAP kinase cascades, as well as by its natural inhibitors (TIMPs) and novel modulators such as interleukins and microRNA. In models of muscle dystrophy and lung cancer metastasis, MMP‑2 not only contributes to matrix degradation but also engages in cross-talk with growth factor receptors (for example, EGFR transactivation) and integrin signalling, thereby influencing cell proliferation, migration, and survival. These insights into MMP‑2 regulation point toward therapeutic strategies that aim to fine-tune its activity to curb pathological remodeling while preserving its role in repair."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "34", "end_ref": "41"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFinally, during development and angiogenesis MMP‑2 functions in concert with other metalloproteinases and membrane‐type MMPs to sculpt the extracellular environment. Its interplay with tissue inhibitors of metalloproteinases (TIMP‑3/4) and its cooperation with enzymes such as MT1‑MMP have been shown to be crucial for proper alveolar septae formation, endothelial cell migration, and the regulation of capillary density. These interactions help define organ structure and function and represent the final layer of regulation that determines whether MMP‑2 activity will result in physiological remodeling or contribute to disease progression."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "42", "end_ref": "47"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "G Matthew Longo, Wanfen Xiong, Timothy C Greiner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI15334"}], "href": "https://doi.org/10.1172/JCI15334"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12208863"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12208863"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Yasuhiko Kawasaki, Zhen-Zhong Xu, Xiaoying Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm1723"}], "href": "https://doi.org/10.1038/nm1723"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18264108"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18264108"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Karsten Grote, Inna Flach, Maren Luchtefeld, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Res (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/01.RES.0000077044.60138.7C"}], "href": "https://doi.org/10.1161/01.RES.0000077044.60138.7C"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12750313"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12750313"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Hilary A Kenny, Swayamjot Kaur, Lisa M Coussens, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI33775"}], "href": "https://doi.org/10.1172/JCI33775"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18340378"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18340378"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Ke-Jie Yin, John R Cirrito, Ping Yan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.2085-06.2006"}], "href": "https://doi.org/10.1523/JNEUROSCI.2085-06.2006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17065436"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17065436"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Takeshi Itoh, Hidetoshi Matsuda, Masatoshi Tanioka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.169.5.2643"}], "href": "https://doi.org/10.4049/jimmunol.169.5.2643"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12193736"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12193736"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Dina M Basalyga, Dan T Simionescu, Wanfen Xiong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/01.CIR.0000148367.08413.E9"}], "href": "https://doi.org/10.1161/01.CIR.0000148367.08413.E9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15545515"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15545515"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Terence M Williams, Freddy Medina, Ines Badano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M409214200"}], "href": "https://doi.org/10.1074/jbc.M409214200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15355971"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15355971"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Lin Zhu, Tao Wang, Federico Perche, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1304987110"}], "href": "https://doi.org/10.1073/pnas.1304987110"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24062440"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24062440"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Bryony S Wiseman, Mark D Sternlicht, Leif R Lund, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.200302090"}], "href": "https://doi.org/10.1083/jcb.200302090"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12975354"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12975354"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Sashwati Roy, Savita Khanna, Syed-Rehan A Hussain, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cardiovasc Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/cvr/cvp015"}], "href": "https://doi.org/10.1093/cvr/cvp015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19147652"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19147652"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Melba Muñoz, Markus M Heimesaat, Kerstin Danker, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20090900"}], "href": "https://doi.org/10.1084/jem.20090900"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19995958"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19995958"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Anna Prudova, Ulrich auf dem Keller, Georgina S Butler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Multiplex N-terminome analysis of MMP-2 and MMP-9 substrate degradomes by iTRAQ-TAILS quantitative proteomics."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Proteomics (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/mcp.M000050-MCP201"}], "href": "https://doi.org/10.1074/mcp.M000050-MCP201"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20305284"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20305284"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Yunchuan Ding, Danmei Xu, Gang Feng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db09-0317"}], "href": "https://doi.org/10.2337/db09-0317"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19509016"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19509016"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Subha Philip, Gopal C Kundu "}, {"type": "b", "children": [{"type": "t", "text": "Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha /IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M207309200"}], "href": "https://doi.org/10.1074/jbc.M207309200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12473670"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12473670"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Jung-Yu C Hsu, Robert McKeon, Staci Goussev, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.1993-06.2006"}], "href": "https://doi.org/10.1523/JNEUROSCI.1993-06.2006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17005848"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17005848"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Ada W Y Chung, Karen Au Yeung, George G S Sandor, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Res (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCRESAHA.107.157776"}], "href": "https://doi.org/10.1161/CIRCRESAHA.107.157776"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17641224"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17641224"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Richard A Dean, Georgina S Butler, Yamina Hamma-Kourbali, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.00821-07"}], "href": "https://doi.org/10.1128/MCB.00821-07"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17908800"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17908800"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "David B Corry, Attila Kiss, Li-Zhen Song, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.03-1412fje"}], "href": "https://doi.org/10.1096/fj.03-1412fje"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15059974"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15059974"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Masafumi Kuzuya, Shigeru Kanda, Takeshi Sasaki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/01.CIR.0000086463.15540.3C"}], "href": "https://doi.org/10.1161/01.CIR.0000086463.15540.3C"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12939223"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12939223"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Mohammad A M Ali, Woo Jung Cho, Bryan Hudson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCULATIONAHA.109.930222"}], "href": "https://doi.org/10.1161/CIRCULATIONAHA.109.930222"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21041693"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21041693"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Vincent Lambert, Ben Wielockx, Carine Munaut, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MMP-2 and MMP-9 synergize in promoting choroidal neovascularization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.03-0113fje"}], "href": "https://doi.org/10.1096/fj.03-0113fje"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14563686"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14563686"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Tracy L Deem, Joan M Cook-Mills "}, {"type": "b", "children": [{"type": "t", "text": "Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2004-02-0665"}], "href": "https://doi.org/10.1182/blood-2004-02-0665"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15265790"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15265790"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Li Tian, Michael Stefanidakis, Lin Ning, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Activation of NMDA receptors promotes dendritic spine development through MMP-mediated ICAM-5 cleavage."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.200612097"}], "href": "https://doi.org/10.1083/jcb.200612097"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17682049"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17682049"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Jian Song, Chuan Wu, Eva Korpos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Focal MMP-2 and MMP-9 activity at the blood-brain barrier promotes chemokine-induced leukocyte migration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2015.01.037"}], "href": "https://doi.org/10.1016/j.celrep.2015.01.037"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25704809"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25704809"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Marina R Bergman, John R Teerlink, Rajeev Mahimkar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Heart Circ Physiol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpheart.00434.2006"}], "href": "https://doi.org/10.1152/ajpheart.00434.2006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17158653"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17158653"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Keiichi Inoue, Yuko Mikuni-Takagaki, Kaoru Oikawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A crucial role for matrix metalloproteinase 2 in osteocytic canalicular formation and bone metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M607290200"}], "href": "https://doi.org/10.1074/jbc.M607290200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16959767"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16959767"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Karim Hnia, Jérôme Gayraud, Gérald Hugon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "L-arginine decreases inflammation and modulates the nuclear factor-kappaB/matrix metalloproteinase cascade in mdx muscle fibers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Pathol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2353/ajpath.2008.071009"}], "href": "https://doi.org/10.2353/ajpath.2008.071009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18458097"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18458097"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Donglei Zhang, Menashe Bar-Eli, Sylvain Meloche, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M313145200"}], "href": "https://doi.org/10.1074/jbc.M313145200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14993222"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14993222"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Kendra J Greenlee, David B Corry, David A Engler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Proteomic identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.177.10.7312"}], "href": "https://doi.org/10.4049/jimmunol.177.10.7312"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17082650"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17082650"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Pallavi Garg, Matam Vijay-Kumar, Lixin Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Gastrointest Liver Physiol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpgi.90454.2008"}], "href": "https://doi.org/10.1152/ajpgi.90454.2008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19171847"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19171847"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Nathalie Augé, Françoise Maupas-Schwalm, Meyer Elbaz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/01.CIR.0000136995.83451.1D"}], "href": "https://doi.org/10.1161/01.CIR.0000136995.83451.1D"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15277330"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15277330"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Vijay Kandalam, Ratnadeep Basu, Thomas Abraham, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCRESAHA.109.209189"}], "href": "https://doi.org/10.1161/CIRCRESAHA.109.209189"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20056917"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20056917"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Satish K Madala, John T Pesce, Thirumalai R Ramalingam, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Matrix metalloproteinase 12-deficiency augments extracellular matrix degrading metalloproteinases and attenuates IL-13-dependent fibrosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.0903008"}], "href": "https://doi.org/10.4049/jimmunol.0903008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20181883"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20181883"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Kayoko Nakaji, Masafumi Ihara, Chiaki Takahashi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter lesions after chronic cerebral hypoperfusion in rodents."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Stroke (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/01.STR.0000244808.17972.55"}], "href": "https://doi.org/10.1161/01.STR.0000244808.17972.55"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17008622"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17008622"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Ayman ElAli, Thorsten R Doeppner, Anil Zechariah, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased blood-brain barrier permeability and brain edema after focal cerebral ischemia induced by hyperlipidemia: role of lipid peroxidation and calpain-1/2, matrix metalloproteinase-2/9, and RhoA overactivation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Stroke (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/STROKEAHA.111.615559"}], "href": "https://doi.org/10.1161/STROKEAHA.111.615559"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21836084"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21836084"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Zhen-Yin Tao, Maria A Cavasin, Fang Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Temporal changes in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarction in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Life Sci (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.lfs.2003.09.042"}], "href": "https://doi.org/10.1016/j.lfs.2003.09.042"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14729404"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14729404"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Heyong Wang, Yingchao Zhu, Mingchuan Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miRNA-29c suppresses lung cancer cell adhesion to extracellular matrix and metastasis by targeting integrin β1 and matrix metalloproteinase2 (MMP2)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0070192"}], "href": "https://doi.org/10.1371/journal.pone.0070192"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23936390"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23936390"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Olivia Fromigué, Zahia Hamidouche, Pierre J Marie "}, {"type": "b", "children": [{"type": "t", "text": "Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M801436200"}], "href": "https://doi.org/10.1074/jbc.M801436200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18757369"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18757369"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Susanne Roelle, Robert Grosse, Achim Aigner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Matrix metalloproteinases 2 and 9 mediate epidermal growth factor receptor transactivation by gonadotropin-releasing hormone."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M304377200"}], "href": "https://doi.org/10.1074/jbc.M304377200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12963732"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12963732"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Junseo Oh, Rei Takahashi, Eijiro Adachi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1207688"}], "href": "https://doi.org/10.1038/sj.onc.1207688"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15064723"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15064723"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Samantha A Oblander, Zhongjun Zhou, Beatriz G Gálvez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Distinctive functions of membrane type 1 matrix-metalloprotease (MT1-MMP or MMP-14) in lung and submandibular gland development are independent of its role in pro-MMP-2 activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dev Biol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ydbio.2004.09.033"}], "href": "https://doi.org/10.1016/j.ydbio.2004.09.033"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15572153"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15572153"}]}, {"type": "r", "ref": 43, "children": [{"type": "t", "text": "M-J Hannocks, X Zhang, H Gerwien, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The gelatinases, MMP-2 and MMP-9, as fine tuners of neuroinflammatory processes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Matrix Biol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.matbio.2017.11.007"}], "href": "https://doi.org/10.1016/j.matbio.2017.11.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29158162"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29158162"}]}, {"type": "r", "ref": 44, "children": [{"type": "t", "text": "Maren Luchtefeld, Karsten Grote, Christina Grothusen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Angiotensin II induces MMP-2 in a p47phox-dependent manner."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2004.12.152"}], "href": "https://doi.org/10.1016/j.bbrc.2004.12.152"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15670768"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15670768"}]}, {"type": "r", "ref": 45, "children": [{"type": "t", "text": "Jane L English, Zamaneh Kassiri, Ilpo Koskivirta, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Individual Timp deficiencies differentially impact pro-MMP-2 activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M512009200"}], "href": "https://doi.org/10.1074/jbc.M512009200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16469749"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16469749"}]}, {"type": "r", "ref": 46, "children": [{"type": "t", "text": "Crystel Ogier, Anne Bernard, Anne-Marie Chollet, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Matrix metalloproteinase-2 (MMP-2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Glia (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/glia.20349"}], "href": "https://doi.org/10.1002/glia.20349"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16845676"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16845676"}]}, {"type": "r", "ref": 47, "children": [{"type": "t", "text": "Dick Wågsäter, Chaoyong Zhu, Johan Björkegren, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the Ldlr(-/-)Apob(100/100) mouse."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijmm.2011.693"}], "href": "https://doi.org/10.3892/ijmm.2011.693"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21567073"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21567073"}]}]}]}
|
| Synonyms | ZNF751, zfp-2 |
| Proteins | ZFP2_HUMAN |
| NCBI Gene ID | 80108 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
ZFP2 has 3,983 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 86 datasets.
Click the + buttons to view associations for ZFP2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of ZFP2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of ZFP2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of ZFP2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of ZFP2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of ZFP2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of ZFP2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of ZFP2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of ZFP2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of ZFP2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of ZFP2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of ZFP2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of ZFP2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with ZFP2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of ZFP2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of ZFP2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of ZFP2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of ZFP2 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of ZFP2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing ZFP2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with ZFP2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of ZFP2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with ZFP2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Disease Associations | diseases associated with ZFP2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by ZFP2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with ZFP2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at ZFP2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of ZFP2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of ZFP2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing ZFP2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of ZFP2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing ZFP2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of ZFP2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of ZFP2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of ZFP2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of ZFP2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of ZFP2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of ZFP2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving ZFP2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving ZFP2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving ZFP2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing ZFP2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by ZFP2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by ZFP2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by ZFP2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of ZFP2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of ZFP2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of ZFP2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of ZFP2 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with ZFP2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with ZFP2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with ZFP2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of ZFP2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of ZFP2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of ZFP2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of ZFP2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of ZFP2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for ZFP2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of ZFP2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of ZFP2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of ZFP2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of ZFP2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with ZFP2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of ZFP2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of ZFP2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain ZFP2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting ZFP2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of ZFP2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of ZFP2 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for ZFP2 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of ZFP2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of ZFP2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| Reactome Pathways 2014 | pathways involving ZFP2 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving ZFP2 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of ZFP2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at ZFP2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of ZFP2 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of ZFP2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of ZFP2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of ZFP2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of ZFP2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of ZFP2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of ZFP2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of ZFP2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of ZFP2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with ZFP2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with ZFP2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |